Table 1.
Allelic frequency of the D-repeat polymorphism of ASPN in DDH in a Han Chinese population
| Group | No. of subject | No. of allele (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| D11 | D12 | D13 | D14 | D15 | D16 | D17 | D18 | Total | ||
| DDH | ||||||||||
| All | 370 | 1 (0.1) | 168 (22.7) | 430 (58.1) | 70 (9.5) | 23 (3.1) | 43 (5.8) | 5 (0.7) | 0 | 740 |
| Female | 313 | 1 (0.2) | 131 (20.9) | 372 (59.4) | 64 (10.2) | 20 (3.2) | 35 (5.6) | 3 (0.5) | 0 | 626 |
| Male | 57 | 0 | 37 (32.4) | 58 (50.8) | 6 (5.2) | 3 (2.6) | 8 (7.0) | 2 (1.8) | 0 | 114 |
| CONTROL | ||||||||||
| All | 445 | 0 | 167 (18.8) | 599 (67.3) | 48 (5.4) | 30 (3.4) | 39 (4.4) | 4 (0.4) | 3 (0.3) | 890 |
| Female | 290 | 0 | 110 (19.0) | 391 (67.4) | 32 (5.5) | 16 (2.8) | 29 (5.0) | 1 (0.2) | 1 (0.2) | 580 |
| Male | 155 | 0 | 57 (18.3) | 208 (67.1) | 16 (5.1) | 14 (4.5) | 10 3.2) | 3 (1.0) | 2 (0.6) | 310 |
ASPN, aspirin; D-repeat, aspartic acid repeat; DDH, developmental dysplasia of the hip.